Improving access through effective payer marketing

Improving access through effective payer marketing

Rhett Johnson, Matthew Majewski
Life Sciences | Pharmaceuticals

More than 80 percent of prescription drugs are paid for by commercial or government payers. However, due to rising pharmaceutical costs, payers are increasingly focused on cost reduction strategies that can result in reduced access and lower profitability for pharmaceutical manufacturers. To secure and sustain favorable access for their products, pharmaceutical manufacturers need to execute payer marketing initiatives that speak directly to payers’ business objectives: quality care at reduced costs. In “Improving access through effective payer marketing,” CRA outlines some of the key elements of a successful payer marketing approach. To read the article, click here:

Download PDF